United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halcinonide cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halcinonide cream, usp, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

glasshouse pharmaceuticals limited canada - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halcinonide cream usp, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halcinonide 1 mg in 1 g - halog ointment (halcinonide ointment, usp) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halog (halcinonide cream, usp) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - halcinonide (unii: si86v6qneg) (halcinonide - unii:si86v6qneg) - halog solution (halcinonide topical solution, usp) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - halcinonide neomycin nystatin - cream

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - halcinonide neomycin nystatin - ointment

Canada - English - Health Canada

bristol-myers squibb canada - halcinonide - ointment - 0.1% - halcinonide 0.1% - anti-inflammatory agents

Canada - English - Health Canada

bristol-myers squibb canada - halcinonide - cream - 0.1% - halcinonide 0.1% - anti-inflammatory agents